Alliance Pharma 

0
85
+€0.00+0% 00:00 Today

Statistics

Day High
-
Day Low
-
52W High
-
52W Low
-
Volume
-
Avg. Volume
-
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-

Dividends

0%Dividend Yield
Jul 2023
€0.01
Jan 2023
€0.01
Jul 2022
€0.01
Jan 2022
€0.01
Jul 2021
€0.01
10Y Growth
N/A
5Y Growth
N/A
3Y Growth
N/A
1Y Growth
N/A

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.

About

Alliance Pharma plc, a holding company, acquires, markets, and distributes consumer healthcare products and prescription medicines in Europe, the Middle East, Africa, the Asia Pacific, China, and the Americas. It provides its products under the Aloclair, Anbesol, Asthon & Parsons, Forceval, Hydromol, Kelo-Cote, MacuShield, Vamousse, Nizoral, and Amberen brand names. The company was incorporated in 1996 and is headquartered in Chippenham, the United Kingdom. As of May 14, 2025, Alliance Pharma plc was taken private.
Show More
CEO
Mr. Nicholas John Sedgwick
Employees
290
Country
United Kingdom
ISIN
GB0031030819
WKN
000913253

Listings

0 Comments

Share your thoughts

FAQs

What is Alliance Pharma stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on Boerse Muenchen exchange Alliance Pharma stocks are traded under the ticker DVL.MU.
Does Alliance Pharma pay dividends?▼
Yes, DVL.MU dividends are paid semi-annual. The last dividend per share was 0.01 . As of today, Dividend Yield (FWD)% is 0%.
How many employees does Alliance Pharma have?▼
As of October 9, 2026, the company has 290 employees.
In which sector is Alliance Pharma located?▼
Alliance Pharma operates in the Health & Wellness sector.
When did Alliance Pharma complete a stock split?▼
Alliance Pharma has not had any recent stock splits.
Where is Alliance Pharma headquartered?▼
Alliance Pharma is headquartered in Chippenham, United Kingdom.